APPLICATION OF AUTOPLASMA ENRICHED WITH PLATELET DERIVED GROWTH FACTOR IN THE TREATMENT OF ERECTILE DYSFUNCTION


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Autoplasma enriched with platelet derived growth factor (AET) is a technology that is included in the scope of regenerative medicine. The main active component of AET is biologically active substance - of growth factors, cytokines and chemokines involved in cell growth, proliferation and cell differentiation in accordance with the tissue species specifity. This article presents information on ingredients of autoplasma, classification of AET preparations; the possible mechanisms of action are discussed, and the results of pre-clinical and clinical trials of AET in various diseases, including erectile dysfunction, are also reviewed.

Толық мәтін

Рұқсат жабық

Авторлар туралы

P. Glybochko

SRI of Uronephrology and Human Reproductive Health of the First MSMU n.a. I.M. Sechenov

M. Chaly

SRI of Uronephrology and Human Reproductive Health of the First MSMU n.a. I.M. Sechenov

M. Yepifanova

SRI of Uronephrology and Human Reproductive Health of the First MSMU n.a. I.M. Sechenov

Email: epifanova_maya@mail.ru
Junior Researcher at the Department of Andrology

N. Akhvlediani

SRI of Uronephrology and Human Reproductive Health of the First MSMU n.a. I.M. Sechenov

A. Krasnov

SRI of Uronephrology and Human Reproductive Health of the First MSMU n.a. I.M. Sechenov

Әдебиет тізімі

  1. П.В Глыбочко, Ю.Г. Аляев, М.Е. Чалый и др. Половые расстройства у мужчин. М.: ГЭОТАР-Медиа, 2012.
  2. Пушкарь Д.Ю., Камалов А.А., Аль-Шукри С.Х. Анализ результатов эпидемиологического исследования распространенности эректильной дисфункции в Российской Федерации. Урология. 2012;6:5-9.
  3. Montorsi F. Verheyden B, Meuleman E. et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur. Urol. 2004;45(3):339-344.
  4. Гамидов С.И., Мазо Е.Б., Овчинников Р.И. и др. Эректильная дисфункция у больных ишемической болезнью сердца (обзор). Терапевтический архив. 2004;76(10):75-80.
  5. Pietrzak W.S., Eppley B.L. Platelet rich plasma: biology and new technology. J. Craniofac. Surg. 2005;16:1043e54.
  6. Assoian R.K., Komoriya A., Meyers C.A. et al. Transforming growth factor-beta in human platelets Identification of a major storage site, purification and characterization. J. Biol. Chem. 1983;258(11):7155-7160.
  7. Фатхуллина Л.С., Джорджикия Р.К., Рахимуллин И.М. и др. Роль трансфузии концентрата тромбоцитов при кардиохирургических операциях. Вестн. соврем. клин. медицины. 2014;7(5):56-59.
  8. Liddle A.D., Rodriguez-Merchan E.C. Platelet-Rich Plasma in the Treatment of Patellar Tendinopathy: A Systematic Review. Am. J. Sports Med. 2014;18. pii:0363546514560726.
  9. Motolese A., Vignati F, Antelmi A., et al. Effectiveness of platelet- rich plasma in healing necrobiosis lipoidica diabeticorum ulcers. Clin. Exp. Dermatol. 2015;40(1):39-41.
  10. Fanning, J., Murrain, L.B.W. Phase I/II prospective trial of autologous platelet tissue graft in gynecologic surgery. J. Minim. Invasive Gynecol. 2007; 14(5):633-637.
  11. Lee S., Zheng Z., Kang J. Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss. Wound Repair Regen. 2014;18. doi: 10.1111/ wrr.12250.
  12. Albanese A., Licata M.E., Polizzi B. et al. Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration. Immun. Ageing. 2013;10(1):23. doi: 10.1186/1742- 4933-10-23.
  13. Lee J.W., Kwon O.H., Kim T.K. et al. Platelet-Rich Plasma: Quantitative Assessment of Growth Factor Levels and Comparative Analysis of Activated and Inactivated Groups. Arch. Plast. Surg. 2013;40:530- 535.
  14. Stiles C.D. The molecular biology of platelet-derived growth factor. Cell. 1983;33:653e5.
  15. Marx R.E., Carlson E.R., Eichstaedt R.M. et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. 1998;85:638-646.
  16. Weiser L., Bhargava M., Attia E., et al. Effect of serum and platelet-derived growth factor on chondrocytes grown in collagen gels. Tissue Eng. 1999;5:533e44.
  17. JohnP. Nitric Oxide and Angiogenesis. Circulation. 2002;105:2133.
  18. Драгунов А.Г., Александров Ю.В., Поляков С.В. и др. Применение внутритканевого введения препарата крови, обогащенной тромбоцитами при лечении ишемии нижних конечностей. Ангиология и сосудистая хирургия. 2008; 14(3): 17-20.
  19. Watanabe T., Okuda Y., Nonoguchi N., et al. Postischemic intraventricular administration of FGF-2 expressing adenoviral vectors improves neurologic outcome and reduces infarct volume after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2004;24( 11):1205-1213.
  20. Jeon O., Kang S.W., Lim H.W. et al. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs. Biomaterials. 2006;27 (8):1617-1625.
  21. David M. Dohan Ehrenfest, Lars Rasmusson and Tomas Albrektsson Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009;27 (3):158-167.
  22. Шевченко Ю.Л. Медико-биологические и физиологические основы клеточной технологии в сердечно-сосудистой хирургии. СПб.: Наука, 2006. 287 с.
  23. Давыденко В.В., Мачс В.М. Стимулированное ангиогенез- новое направление в лечении при ишемических состояниях. Вестн. хирургии. им. И.И. Грекова. 2000;159(4) :117-120.
  24. Xie D., Pippen A.M., Odronic S.I. et al. Intracavernosal basic fibroblast growth factor improves vasoreactivity in the hypercholesterolemic rabbit. J. Sex Med. 2006;3(2):223-232.
  25. Suetomi T., Hisasue S., Sato Y. et al. Effect of basic fibroblast growth factor incorporating gelatin microspheres on erectile function in the diabetic rat. J. Urol. 2005; 173(4): 1423-1428.
  26. Dai Q., Silverstein A.D., Davies M.G. et al. Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J. Urol. 2003; 170(2 Pt. 1):664-668.
  27. Wu Y.N., Wu C.C., Sheu M.T. et al. Optimization of platelet-rich plasma and its effects on the recovery of erectile function after bilateral cavernous nerve injury in a rat model. J. of Tissue Eng. Regen. Med. 2013;16. doi: 10.1002/term.1806.
  28. Wu C.C., Wu Y.N., Ho H.O. et al. Chiang The neuroprotective effect of platelet-rich plasma on erectile function in bilateral cavernous nerve injury rat model. J. Sex Med. 2012;9(11): 2838-2848.
  29. Чалый М.Е. Вилькин Я.Ф., Епифанова М.В. Способ лечения эректильной дисфункции [патент] РФ № 2514639.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2015